| Contact Details | #327, Software & ICT Hall, 152, Jukjeon-ro, Suji-gu, Yongin, 16890 031-706-8730rznomics@rznomics.com |
|---|
Rznomics
Category:
Venture
Main Business Area
Rznomics is a biotech company that develops gene therapies for cancer and incurable diseases based on RNA Platform technology. They aim to meet various unmet medical needs through their innovative gene therapies. Their RNA platform technology allows them to develop a wide range of therapeutics for various diseases.
Find out more companies
Related products
-
-
-
-
VentureAprogen
Their main modalities include SDR-Grafting, Recombinant Protein Fusion, CHIMPS Bispecific Antibodies, SHOCAP Bispecific Antibodies, and Bitargeting Receptor-Antibody Hybrid
-
